Annual ROE
-126.06%
-49.10%-63.80%
December 31, 2023
Summary
- As of March 12, 2025, FNCH annual return on equity is -126.06%, with the most recent change of -49.10% (-63.80%) on December 31, 2023.
- During the last 3 years, FNCH annual ROE has fallen by -167.16% (-406.72%).
- FNCH annual ROE is now -406.72% below its all-time high of 41.10%, reached on December 31, 2020.
Performance
FNCH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-69.14%
-1.03%-1.51%
June 30, 2024
Summary
- As of March 12, 2025, FNCH quarterly return on equity is -69.14%, with the most recent change of -1.03% (-1.51%) on June 30, 2024.
- Over the past year, FNCH quarterly ROE has increased by +127.93% (+64.92%).
- FNCH quarterly ROE is now -268.22% below its all-time high of 41.10%, reached on December 31, 2020.
Performance
FNCH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FNCH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.8% | +64.9% |
| 3 y3 years | -406.7% | +64.9% |
| 5 y5 years | -461.6% | +64.9% |
FNCH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.8% | at low | -115.1% | +74.7% |
| 5 y | 5-year | -406.7% | at low | -268.2% | +74.7% |
| alltime | all time | -406.7% | at low | -268.2% | +74.7% |
Finch Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -69.14%(+1.5%) |
| Mar 2024 | - | -68.11%(-75.0%) |
| Dec 2023 | -126.06%(+63.8%) | -272.96%(+26.1%) |
| Sep 2023 | - | -216.53%(+9.9%) |
| Jun 2023 | - | -197.07%(+52.2%) |
| Mar 2023 | - | -129.52%(+71.2%) |
| Dec 2022 | -76.96% | -75.66%(+25.1%) |
| Sep 2022 | - | -60.50%(+56.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -38.56%(+20.0%) |
| Mar 2022 | - | -32.14%(-12.3%) |
| Dec 2021 | -109.21%(-365.7%) | -36.63%(+3.8%) |
| Sep 2021 | - | -35.28%(-16.4%) |
| Jun 2021 | - | -42.21%(-33.2%) |
| Mar 2021 | - | -63.20%(-253.8%) |
| Dec 2020 | 41.10%(+17.9%) | 41.10% |
| Dec 2019 | 34.86% | - |
FAQ
- What is Finch Therapeutics annual return on equity?
- What is the all time high annual ROE for Finch Therapeutics?
- What is Finch Therapeutics annual ROE year-on-year change?
- What is Finch Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Finch Therapeutics?
- What is Finch Therapeutics quarterly ROE year-on-year change?
What is Finch Therapeutics annual return on equity?
The current annual ROE of FNCH is -126.06%
What is the all time high annual ROE for Finch Therapeutics?
Finch Therapeutics all-time high annual return on equity is 41.10%
What is Finch Therapeutics annual ROE year-on-year change?
Over the past year, FNCH annual return on equity has changed by -49.10% (-63.80%)
What is Finch Therapeutics quarterly return on equity?
The current quarterly ROE of FNCH is -69.14%
What is the all time high quarterly ROE for Finch Therapeutics?
Finch Therapeutics all-time high quarterly return on equity is 41.10%
What is Finch Therapeutics quarterly ROE year-on-year change?
Over the past year, FNCH quarterly return on equity has changed by +127.93% (+64.92%)